LONDON–(BUSINESS WIRE)–Aug 26, 2020–
The mycoplasma testing market is expected to register a CAGR of over 11% during 2020-2024, as per the latest research report by Technavio. The report offers a detailed analysis of the impact of COVID-19 pandemic on the market in optimistic, probable, and pessimistic forecast scenarios.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200826005041/en/
Technavio has announced its latest market research report titled Global Mycoplasma Testing Market 2020-2024 (Graphic: Business Wire)
Request for Technavio’s market report estimates including pre- and post-COVID-19 impact on mycoplasma testing market.Download a Free Sample Reporton the impact of COVID-19 pandemic analysis.
Due to the extensive spread of the virus across the globe, the Health Care Industry is anticipated to have Positive impact. The mycoplasma testing market will showcase Neutral impact during 2020-2024.
Mycoplasma Testing Market 2020-2024: Segmentation
Mycoplasma Testing Market is segmented as below:
- Product
- Geography
- North America
- Europe
- Asia
- ROW
- End-user
- Pharmaceutical and Biotechnology Companies
- CROs
- Cell Banks
- Academic Research Institutes
- Others
North America region will account for the highest incremental growth during the forecast period due to the increasing number of life science researches and the presence of life science research firms and laboratories.
With the surging growth of COVID-19 pandemic, the Health Care market is anticipated to have a direct impact during the forecast period.View market snapshot before purchasing
Growing M&A and partnerships between CROs, and pharmaceutical and biotechnology companies has been an instrumental factor in influencing the growth of mycoplasma testing market. Other market drivers include increasing initiatives and funding for mycoplasma testing and rise in adoption of real-time mycoplasma testing. Technavio offers custom research analysis on the crucial pointers to highlight the impact of COVID-19 on the market across the supply chain.
Key Considerations for Market Forecast:
- Impact of lockdowns, supply chain disruptions, demand destruction, and change in customer behavior
- Optimistic, probable and pessimistic scenarios for all markets as the impact of pandemic unfolds
- Pre- as well as post-COVID 19 market estimates
- Quarterly impact analysis and updates on market estimates
Get more insights about the global trends impacting the future of mycoplasma testing market, Request Free Sample @https://www.technavio.com/talk-to-us?report=IRTNTR43492
Mycoplasma Testing Market 2020-2024: Vendor Analysis
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Key players in the market have been launching several initiatives and introducing innovative products and services to cater to a larger target audience during the pandemic. Major market participants include Agilent Technologies Inc., ATCC, Becton, Dickinson and Co., Charles River Laboratories International Inc., F. Hoffmann-La Roche Ltd., InvivoGen, Lonza Group Ltd., Merck KGaA, Norgen Biotek Corp., and Thermo Fisher Scientific Inc.
Technavio’s custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Register for a free trial today and gain instant access to 17,000+ market research reports.Technavio’s SUBSCRIPTION platform
Table of Contents:
Executive Summary
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 – 2024
Five Forces Analysis
- Five Force Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Consumables – Market size and forecast 2019-2024
- Systems – Market size and forecast 2019-2024
- Market opportunity by Product
Market Segmentation by End-user
- Pharmaceutical and biotechnology companies
- CROs
- Academic research institutes
- Cell banks
- Others
Customer Landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America – Market size and forecast 2019-2024
- Europe – Market size and forecast 2019-2024
- Asia – Market size and forecast 2019-2024
- ROW – Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Volume driver – demand led growth
- Market challenges
- Market trends
Vendor Landscape
- Vendor landscape
- Landscape disruption
- Competitive scenario
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Agilent Technologies Inc.
- ATCC
- Charles River Laboratories International Inc.
- F. Hoffmann-La Roche Ltd.
- InvivoGen
- Lonza Group Ltd.
- Merck KGaA
- Norgen Biotek Corp.
- Thermo Fisher Scientific Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200826005041/en/
CONTACT: Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:[email protected]
Website:www.technavio.com/
KEYWORD:
INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH
SOURCE: Technavio Research
Copyright Business Wire 2020.
PUB: 08/26/2020 05:00 AM/DISC: 08/26/2020 05:00 AM
Copyright Business Wire 2020.
